EHA 2021 Virtual Congress
Publication date: Available online 18 June 2021Source: The Lancet HaematologyAuthor(s): Owen Stretton (Source: The Lancet Haematology)
Source: The Lancet Haematology - June 20, 2021 Category: Hematology Source Type: research
Bleeding disorders: adapting to change
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): The Lancet Haematology (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research
A+AVD versus eBEACOPP in advanced-stage Hodgkin lymphoma
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): Louis F Diehl (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research
Maintaining the minimal: dynamics of measurable residual disease with continuous lenalidomide therapy
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): Susan Bal, Luciano J Costa (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research
Anti-CD25 antibody–drug conjugates: improving the delivery of death to lymphoma cells?
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): Norbert Schmitz, Georg Lenz (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research
Correction to Lancet Haematol 2021; 8: e185–93
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research
Correction to Lancet Haematol 2021; 8: e205–15
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research
PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): Stefanie Kreissl, Helen Goergen, Ina Buehnen, Carsten Kobe, Alden Moccia, Richard Greil, Dennis A Eichenauer, Josée M Zijlstra, Jana Markova, Julia Meissner, Michaela Feuring-Buske, Martin Soekler, Hans-Joachim Beck, Wolfgang Willenbacher, Wolf-Dieter Ludwig, Thomas Pabst, Max S Topp, Felicitas Hitz, Martin Bentz, Ulrich Bernd Keller (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research
Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): David J Straus, Monika Długosz-Danecka, Joseph M Connors, Sergey Alekseev, Árpád Illés, Marco Picardi, Ewa Lech-Maranda, Tatyana Feldman, Piotr Smolewski, Kerry J Savage, Nancy L Bartlett, Jan Walewski, Radhakrishnan Ramchandren, Pier Luigi Zinzani, Martin Hutchings, Javier Munoz, Hun Ju Lee, Won Seog Kim, Ranjana Advani, Stephen M Ansell (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research
Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): Benjamin Diamond, Neha Korde, Alexander M Lesokhin, Eric L Smith, Urvi Shah, Sham Mailankody, Malin Hultcrantz, Hani Hassoun, Sydney X Lu, Carlyn Tan, Even H Rustad, Francesco Maura, Kylee Maclachlan, Tim Peterson, Andriy Derkach, Sean Devlin, Heather J Landau, Michael Scordo, David J Chung, Gunjan L Shah (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research
Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): Mehdi Hamadani, Graham P Collins, Paolo F Caimi, Felipe Samaniego, Alexander Spira, Andrew Davies, John Radford, Tobias Menne, Anand Karnad, Jasmine M Zain, Paul Fields, Karin Havenith, Hans G Cruz, Shui He, Joseph Boni, Jay Feingold, Jens Wuerthner, Steven Horwitz (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research
CAR T-cell therapy for multiple myeloma: state of the art and prospects
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): Niels W C J van de Donk, Saad Z Usmani, Kwee Yong (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research
Eliminating race-based reference ranges in haematology: a call to action
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): Angela C Weyand, Patrick T McGann (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research
Matthew Fowler: driving advanced nursing practice in haematology
Publication date: Available online 11 May 2021Source: The Lancet HaematologyAuthor(s): Nayanah Siva (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 13, 2021 Category: Hematology Source Type: research
Global collaboration led by the EBMT Nurses Group
Publication date: Available online 11 May 2021Source: The Lancet HaematologyAuthor(s): Eugenia Trigoso, Julia Ruiz, Michelle Kenyon, John Murray (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 13, 2021 Category: Hematology Source Type: research
